Beranda › Kanker Kolorektal › Virginia › Roanoke
Uji klinis Kanker Kolorektal di Roanoke, VA
10 studi untuk Kanker Kolorektal mencari peserta di lokasi sekitar Roanoke (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
Menerima pesertaFase 3
- Blue Ridge Cancer Care - Blacksburg /ID# 280115, Blacksburg · 26 mi jauhnya
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Menerima pesertaFase 3
- Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care, Roanoke
- Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care, Salem · 6 mi jauhnya
- Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care, Blacksburg · 26 mi jauhnya
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
Menerima pesertaFase 1/2
- Oncology and Hematology Associates of Southwest Virginia (BRCC) ( Site 0295), Roanoke
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
Menerima pesertaFase 3
- Blue Ridge Cancer Care - 300202915, Roanoke
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Menerima pesertaFase 1/2
- Oncology & Hematology Associates of Southwest Virginia, Roanoke
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Menerima pesertaFase 3
- Oncology & Hematology Associates of Southwest Virginia Inc dba Blue Ridge Cancer Care, Roanoke
- Oncology & Hematology Associates of Southwest Virginia, Inc. D.B.A Blue Ridge Cancer Care, Salem · 6 mi jauhnya
- Oncology & Hematology Associates of Southwest Virginia, Inc. D.B.A Blue Ridge Cancer Care, Blacksburg · 26 mi jauhnya
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
Menerima pesertaFase 2
- Blue Ridge Cancer Care, Salem · 6 mi jauhnya
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
Menerima pesertaFase 2
- Blue Ridge Cancer Care (Oncology & Hematology Associates of Southwest VA), Salem · 6 mi jauhnya
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Menerima pesertaFase 3Sukarelawan sehat diterima
- Carilion Roanoke Memorial Hospital, Roanoke
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Menerima pesertaStudi observasional
- Carilion Roanoke Memorial Hospital, Roanoke
Uji klinis Kanker Kolorektal di kota lain
- Houston, TX102 studi
- New York City, NY78 studi
- Nashville, TN69 studi
- Boston, MA63 studi
- Los Angeles, CA59 studi
- Arlington, VA52 studi
- St. Louis, MO50 studi
- San Antonio, TX46 studi
- Philadelphia, PA44 studi
- Grand Rapids, MI40 studi
- Baldwin Park, CA37 studi
- Chicago, IL34 studi
Studi lain di Roanoke
- Gagal Jantung9 studi
- Kanker Paru Non-Sel Kecil8 studi
- Kanker Payudara7 studi
- Kanker Prostat7 studi
- Kanker Metastatik6 studi
- Kaki Diabetes5 studi
- Kanker Lambung4 studi
- Melanoma4 studi
- Penyakit Crohn4 studi
- Kanker Paru Sel Kecil4 studi
- Kanker Ovarium4 studi
- Obesitas4 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.